A hidden phase of Alzheimer’s appears decades before symptoms, offering a chance for early detection and treatment.

A man in his 70s from Oklahoma could provide a key to Alzheimer's disease, as scientists are rethinking the underlying cause ...

Despite familiarity with cognitive screening and its benefits, current and emerging screening and testing tools for Alzheimer’s disease and related dementias remain vastly underused, according to ...

Most shocking to CARD workers was the termination of lead researcher Kendall Van Keuren-Jensen, who was announced internally ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A model ...

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...

The article highlights the potentially game-changing approach of the Company towards treating Alzheimer’s Disease, based on technology developed at Rutgers by Dr. Luciano D’Adamio, PhD, MD, New Jersey ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

“There is still a dire need for more effective treatments for Alzheimer’s Disease,” said Marco Taglietti, MD, Chief Executive Officer of NanoNewron. “Despite decades of research, the ...

New research suggests that consistent aerobic exercise could be a powerful tool in reducing the biological signs associated ...

Alzheimer's disease (AD), the most common form of dementia, continues to remain one of modern medicine's greatest challenges.

Improve doctors’ ability to tailor treatment doses to an individual’s needs. Provide new ways to measure the effects of drugs used to treat dementia. Sleep disturbances are common in dementia and can ...